Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$502,075
-$49,690 QoQ
Shares Held
3,974
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,371
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Choate Investment Advisors holds $157,042,184 across 12 Drug Manufacturers - General names. GILD ranks #12 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,791 | $60,920,254 | |
| 2 | JNJ |
Johnson & Johnson
|
184,823 | $46,939,497 | |
| 3 | ABBV |
AbbVie Inc.
|
71,634 | $18,025,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
94,736 | $12,173,576 | |
| 5 | NVS |
Novartis AG
|
29,237 | $4,582,022 | |
| 6 | AMGN |
Amgen Inc
|
12,190 | $4,414,242 | |
| 7 | PFE |
Pfizer Inc
|
142,810 | $3,438,864 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
42,788 | $2,465,444 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $502,075 | 3,974 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $551,765 | 3,959 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $446,650 | 3,639 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $394,716 | 3,556 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $395,805 | 3,570 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,098,986 | 9,808 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $898,021 | 9,722 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $785,496 | 9,369 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $651,520 | 9,496 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $712,869 | 9,732 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $840,640 | 10,377 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $753,296 | 10,052 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $747,116 | 9,694 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $708,065 | 8,534 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $743,890 | 8,665 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $510,793 | 8,280 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $511,786 | 8,280 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $493,375 | 8,299 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $612,392 | 8,434 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $590,931 | 8,460 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $584,208 | 8,484 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $531,193 | 8,219 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $478,838 | 8,219 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $519,358 | 8,219 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $789,712 | 10,264 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $842,096 | 11,264 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||